EcoDrugPlus

Adrenoceptor Beta 2

Ensembl ID : ENSCDRG00005003202
Gene Symbol: ADRB2
3 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSCDRG00005015401
Gene Symbol: ADRB3
1 Cross references
218 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSCDRG00005021314
Gene Symbol: AGER
1 Cross references
170 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSCDRG00005006442
Gene Symbol: ADH5
3 Cross references
405 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSCDRG00005001802
Gene Symbol: AKR1B1
2 Cross references
422 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSCDRG00005018090
Gene Symbol: GAA
1 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSCDRG00005008235
Gene Symbol: AOC1
3 Cross references
233 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSCDRG00005010395
Gene Symbol: AOC3
3 Cross references
327 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSCDRG00005000511
Gene Symbol: APP
3 Cross references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSCDRG00005013801
Gene Symbol: AR
1 Cross references
277 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSCDRG00005021606
Gene Symbol: ACE
3 Cross references
92 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSCDRG00005013859
Gene Symbol: AGTR1
1 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).